A composite of major kidney disease events was the primary outcome of the trial and consisted of onset of kidney failure, a 50% or greater reduction in eGFR from baseline, or kidney or CV-related mortality
A box of 120 capsules lasts 30 days (4 capsules/day)
For selectivity studies, recombinant GSTO1 (1 M), PDI (1 M), BSA (1 M) or GRP78 (1 M) in reaction buffer were incubated with C1-27 or DMSO for 30 min at 37 C, followed by incubation with CMFDA (500 nM), BODIPY- C1-27A (1 M) or DMSO for 30 min
" The word doing the work in that sentence is clinical
Investors: FCC Capital, Emmertech, iSelect, and BDC Capital
Starting with Subpar Material: Honestly, this is the big one